1
|
Varela G and Thomas PA: Surgical
management of advanced non-small cell lung cancer. J Thorac Dis.
6(Suppl 2): S217–S223. 2014.PubMed/NCBI
|
2
|
Schreiner W, Semrau S, Fietkau R and Sirbu
H: Oligometastatic non-small cell lung cancer - surgical options
and therapy strategies. Zentralbl Chir. 139:335–341. 2014.In
German. PubMed/NCBI
|
3
|
Bolca C, Dănăilă O, Paleru C and Cordoş I:
Role of surgery in small cell lung cancer. Pneumologia. 62:236–238.
2013.In Romanian.
|
4
|
Hosono MN, Hosono M, Endo K, Ueda R and
Onoyama Y: Effect of hyperthermia on tumor uptake of radiolabeled
anti-neural cell adhesion molecule antibody in small-cell lung
cancer xenografts. J Nucl Med. 35:504–509. 1994.PubMed/NCBI
|
5
|
Kawahara T, Ito H, Terao H, Kato Y, Uemura
H, Kubota Y and Matsuzaki J: Effectiveness of ureteroscopy-assisted
retrograde nephrostomy (UARN) for percutaneous nephrolithotomy
(PCNL). PLoS One. 7:e521492012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Alexander ES and Dupuy DE: Lung cancer
ablation: Technologies and techniques. Semin Intervent Radiol.
30:141–150. 2013. View Article : Google Scholar :
|
7
|
Roberton BJ, Liu D, Power M, Wan JM,
Stuart S, Klass D and Yee J: Pulmonary ablation: A primer. Can
Assoc Radiol J. 65:177–185. 2014. View Article : Google Scholar
|
8
|
Lanuti M, Sharma A, Willers H, Digumarthy
SR, Mathisen DJ and Shepard JA: Radiofrequency ablation for stage I
non-small cell lung cancer: Management of locoregional recurrence.
Ann Thorac Surg. 93:921–927; discussion 927–988. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Goldberg SN, Gazelle GS, Compton CC,
Mueller PR and Tanabe KK: Treatment of intrahepatic malignancy with
radiofrequency ablation: Radiologic-pathologic correlation. Cancer.
88:2452–2463. 2000. View Article : Google Scholar : PubMed/NCBI
|
10
|
Yamada S, Utsunomiya T, Morine Y, Imura S,
Ikemoto T, Arakawa Y, Kanamoto M, Iwahashi S, Saito Y, Takasu C, et
al: Expressions of hypoxia-inducible factor-1 and epithelial cell
adhesion molecule are linked with aggressive local recurrence of
hepatocellular carcinoma after radiofrequency ablation therapy. Ann
Surg Oncol. 21(Suppl 3): S436–S442. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Beland MD, Wasser EJ, Mayo-Smith WW and
Dupuy DE: Primary non-small cell lung cancer: Review of frequency,
location, and time of recurrence after radiofrequency ablation.
Radiology. 254:301–307. 2010.
|
12
|
Fraga A, Ribeiro R and Medeiros R: Tumor
hypoxia: The role of HIF. Actas Urol Esp. 33:941–951. 2009.In
Spanish. View Article : Google Scholar : PubMed/NCBI
|
13
|
Wan J, Ma J, Mei J and Shan G: The effects
of HIF-1alpha on gene expression profiles of NCI-H446 human small
cell lung cancer cells. J Exp Clin Cancer Res. 28:1502009.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Wan J, Chai H, Yu Z, Ge W, Kang N, Xia W
and Che Y: HIF-1α effects on angiogenic potential in human small
cell lung carcinoma. J Exp Clin Cancer Res 30. 77:2011. View Article : Google Scholar
|
15
|
Tsui L, Fong TH and Wang IJ: YC-1
targeting of hypoxia-inducible factor-1α reduces RGC-5 cell
viability and inhibits cell proliferation. Mol Vis. 18:1594–1603.
2012.
|
16
|
Nijkamp MW, van der Bilt JD, de Bruijn MT,
Molenaar IQ, Voest EE, van Diest PJ, Kranenburg O and Borel Rinkes
IH: Accelerated perinecrotic outgrowth of colorectal liver
metastases following radiofrequency ablation is a hypoxia-driven
phenomenon. Ann Surg. 249:814–823. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Holleran JL, Miller CJ, Edgehouse NL,
Pretlow TP and Culp LA: Differential experimental micrometastasis
to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma
cells. Clin Exp Metastasis. 19:17–24. 2002. View Article : Google Scholar : PubMed/NCBI
|
18
|
Bott MJ and Crabtree T: Treatment of stage
I lung cancer in high-risk and inoperable patients: SBRT vs. RFA
vs. sublobar resection. Ann Cardiothorac Surg. 3:167–169.
2014.PubMed/NCBI
|
19
|
Baisi A, Raveglia F, De Simone M and
Cioffi U: Palliative role of percutaneous radiofrequency ablation
for severe hemoptysis in an elderly patient with inoperable lung
cancer. J Thorac Cardiovasc Surg. 140:1196–1197. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kelekis AD, Thanos L, Mylona S, Ptohis N,
Malagari K, Nikita A, Christodoulidou J and Kelekis N: Percutaneous
radiofrequency ablation of lung tumors with expandable needle
electrodes: Current status. Eur Radiol. 16:2471–2482. 2006.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Kashima M, Yamakado K, Takaki H, Kodama H,
Yamada T, Uraki J and Nakatsuka A: Complications after 1000 lung
radiofrequency ablation sessions in 420 patients: A single center's
experiences. AJR Am J Roentgenol. 197:W576–W580. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Baisi A, Raveglia F, De Simone M and
Cioffi U: Recurrence after radiofrequency ablation for stage I
non-small cell lung cancer. Ann Thorac Surg. 94:1788–1789. 2012.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Mulier S, Ni Y, Jamart J, Ruers T, Marchal
G and Michel L: Local recurrence after hepatic radiofrequency
coagulation: Multivariate meta-analysis and review of contributing
factors. Ann Surg. 242:158–171. 2005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Nijkamp MW, Borren A, Govaert KM,
Hoogwater FJ, Molenaar IQ, van Diest PJ, Kranenburg O and Borel
Rinkes IH: Radiofrequency ablation of colorectal liver metastases
induces an inflammatory response in distant hepatic metastases but
not in local accelerated outgrowth. J Surg Oncol. 101:551–556.
2010. View Article : Google Scholar : PubMed/NCBI
|
25
|
Okhunov Z, Roy O, Duty B, Waingankar N,
Herati A, Morgenstern N, Sheikh-Fayyaz S and Kavoussi LR: Clinical
evaluation of a novel bipolar radiofrequency ablation system for
renal masses. BJU Int. 110:688–691. 2012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Stoeckelhuber BM, Noack F, Kapsimalakou S,
Rudolf I, Bergmann-Koester CU, Helmberger T and Stoeckelhuber M:
Radiofrequency ablation in breast tissue: Experimental study for
evaluation of radiofrequency effects in the bovine udder and review
of the literature. J Vasc Interv Radiol. 20:1477–1482. 2009.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Frich L, Bjørnland K, Pettersen S, Clausen
OP and Gladhaug IP: Increased activity of matrix metalloproteinase
2 and 9 after hepatic radiofrequency ablation. J Surg Res.
135:297–304. 2006. View Article : Google Scholar : PubMed/NCBI
|
28
|
Takagi H, Azuma K, Tsuka T, Imagawa T,
Osaki T and Okamoto Y: Antitumor effects of high-temperature
hyperthermia on a glioma rat model. Oncol Lett. 7:1007–1010.
2014.PubMed/NCBI
|
29
|
Chen EY, Samkoe KS, Hodge S, Tai K, Hou H,
Petryk AA, Strawbridge R, Hoopes PJ and Khan N: Modulation of
hypoxia by magnetic nanoparticle hyperthermia to augment
therapeutic index. Adv Exp Med Biol. 812:87–95. 2014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Brocato J, Chervona Y and Costa M:
Molecular responses to hypoxia-inducible factor 1α and beyond. Mol
Pharmacol. 85:651–657. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Mittal K, Ebos J and Rini B: Angiogenesis
and the tumor micro-environment: Vascular endothelial growth factor
and beyond. Semin Oncol. 41:235–251. 2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Shahneh FZ, Baradaran B, Zamani F and
Aghebati-Maleki L: Tumor angiogenesis and anti-angiogenic
therapies. Hum Antibodies. 22:15–19. 2013.PubMed/NCBI
|
33
|
Nikfarjam M, Muralidharan V and Christophi
C: Altered growth patterns of colorectal liver metastases after
thermal ablation. Surgery. 139:73–81. 2006. View Article : Google Scholar
|
34
|
Pati S, Orsi SA, Moore AN and Dash PK:
Intra-hippocampal administration of the VEGF receptor blocker
PTK787/ZK222584 impairs long-term memory. Brain Res. 1256:85–91.
2009. View Article : Google Scholar :
|
35
|
Selvarajah GT, Bonestroo FA, Kirpensteijn
J, Kik MJ, van der Zee R, van Eden W, Timmermans-Sprang EP, Slob A
and Mol JA: Heat shock protein expression analysis in canine
osteosarcoma reveals HSP60 as a potentially relevant therapeutic
target. Cell Stress Chaperones. 18:607–622. 2013. View Article : Google Scholar : PubMed/NCBI
|
36
|
Katschinski DM, Le L, Heinrich D, Wagner
KF, Hofer T, Schindler SG and Wenger RH: Heat induction of the
unphosphorylated form of hypoxia-inducible factor-1alpha is
dependent on heat shock protein-90 activity. J Biol Chem.
277:9262–9267. 2002. View Article : Google Scholar : PubMed/NCBI
|
37
|
Guo W, Yang Z, Xia Q, Liu J, Yu Y, Li J,
Zuo Z, Zhang D, Li X, Shi X, et al: Arsenite stabilizes HIF-1α
protein through p85α-mediated up-regulation of inducible Hsp70
protein expression. Cell Mol Life Sci. 68:475–488. 2011. View Article : Google Scholar
|
38
|
Bruns AF, Yuldasheva N, Latham AM, Bao L,
Pellet-Many C, Frankel P, Stephen SL, Howell GJ, Wheatcroft SB,
Kearney MT, et al: A heat-shock protein axis regulates VEGFR2
proteolysis, blood vessel development and repair. PLoS One.
7:e485392012. View Article : Google Scholar : PubMed/NCBI
|
39
|
Ahmed M, Liu Z, Lukyanov AN, Signoretti S,
Horkan C, Monsky WL, Torchilin VP and Goldberg SN: Combination
radiofrequency ablation with intratumoral liposomal doxorubicin:
Effect on drug accumulation and coagulation in multiple tissues and
tumor types in animals. Radiology. 235:469–477. 2005. View Article : Google Scholar : PubMed/NCBI
|
40
|
Veenendaal LM, van Hillegersberg R,
Smakman N, van der Bilt JD, van Diest PJ, Kranenburg O and Borel
Rinkes IH: Synergistic effect of interstitial laser coagulation and
doxorubicin in a murine tumor recurrence model of solitary
colorectal liver metastasis. Ann Surg Oncol. 13:168–175. 2006.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Isbert C, Ritz JP, Roggan A, Schuppan D,
Rühl M, Buhr HJ and Germer CT: Enhancement of the immune response
to residual intrahepatic tumor tissue by laser-induced
thermotherapy (LITT) compared to hepatic resection. Lasers Surg
Med. 35:284–292. 2004. View Article : Google Scholar : PubMed/NCBI
|